IGEM Therapeutics Announces UK Government Funding to Develop a Novel IgE Antibody Targeting Solid Tumours
May 9, 2018
£1.45 million grant from Innovate UK Biomedical Catalyst Funds enable IGEM to progress second product candidate towards the clinic London, 9 May 2018 – IGEM